Holden Thorp became Editor-in-Chief of the Science family of journals in October 2019. He came to Science from Washington University in St. Louis, where he was provost from 2013 to 2019 and where he is Rita Levi-Montalcini Distinguished University Professor and holds appointments in both chemistry and medicine. Thorp earned a bachelor of science degree in chemistry from UNC in 1986 and a doctorate in chemistry in 1989 at the California Institute of Technology. He holds an honorary doctor of laws degree from North Carolina Wesleyan College and is a fellow of the American Academy of Arts and Sciences, the National Academy of Inventors, and the American Association for the Advancement of Science.
Thorp cofounded Viamet Pharmaceuticals, which developed oteseconazole, now held by Mycovia Pharmaceuticals and launching in 2022. He is a venture partner at Hatteras Venture Partners, a consultant to Ancora, and is on the board of directors of the College Advising Corps, PBS, and Artizan Biosciences.